Top Markets
Coin of the day
Telo Genomics Corp. Telo Genomics Corp.

Telo Genomics Corp.

TELO
Clasificación en acciones #35884
Telo Genomics Corp. (TELO.V) operates as a biotechnology firm focused on... Telo Genomics Corp. (TELO.V) operates as a biotechnology firm focused on creating and bringing to market advanced predictive solutions. Its core mission is to enable personalized treatment approaches for individuals suffering from specific health conditions. The company's primary innovation is a sophisticated telomere analysis platform, which serves both to diagnose diseases and to forecast patient outcomes. This technology, often integrated with liquid biopsies, provides crucial insights for applications in both cancer and neurological illnesses. Their leading product, Telo-MM, is specifically designed to arm medical professionals with vital, actionable information for effectively managing Multiple Myeloma, a serious blood cancer. Additionally, Telo Genomics offers TeloView, a proprietary software system capable of precisely measuring individual patient telomere characteristics. Telo Genomics caters to a broad spectrum of clients, including diagnostic pathologists, clinical doctors, academic researchers, and pharmaceutical developers. A notable endorsement of its technology is a collaborative agreement with the renowned Mayo Clinic, aimed at validating the Telo-MM diagnostic tests for multiple myeloma. Founded in 2014 and based in Toronto, Canada, the company adopted its current name, Telo Genomics Corp., in April 2019, having previously operated as 3D Signatures Inc.
Precio por acción
$0.03302716
Última sincronización: 2026-08-13
Capitalización bursátil
$3.32M
Cambio (1 día)
0.00%
Cambio (1 año)
-34.80%
País
CA
Comercio Telo Genomics Corp. (TELO)

Categoría

Ratio P/B de Telo Genomics Corp. (TELO)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Telo Genomics Corp., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Telo Genomics Corp. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
4.1431 -
US
2.7156 -
US
- -
CN
24.3791 -
US
27.366 -
US